Cargando…
1661. Evaluation of Cefazolin < 3 g vs. 3 g Treatment Doses for Cellulitis in Patients Who Weigh ≥ 120 kg within a Large, Community Health System
BACKGROUND: Cefazolin 3 g is recommended for obese patients weighing > 120 kg preoperatively; however, there is no available evidence to suggest 3 g for treatment dosing of cefazolin in this population. This study aims to provide the first clinical data of its kind on the efficacy and safety of h...
Autores principales: | Gens, Krista, Wankum, Michael, Hirsch, Elizabeth B, Gagnon, Brandon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751635/ http://dx.doi.org/10.1093/ofid/ofac492.127 |
Ejemplares similares
-
1753. Impact of a Pharmacist-Driven Home Hospital Antimicrobial Stewardship Program Pilot within a Large Community Health System
por: Nguyen, Van, et al.
Publicado: (2022) -
Continuous renal replacement therapy in neonates weighing less than 3 kg
por: Sohn, Young Bae, et al.
Publicado: (2012) -
Susceptibility of CTLA-4 −1661A/G polymorphism towards severity of rheumatic heart disease
por: Bansal, Ankit, et al.
Publicado: (2021) -
Association between CTLA-4 60G/A and -1661A/G Polymorphisms and the Risk of Cancers: A Meta-Analysis
por: Yan, Qing, et al.
Publicado: (2013) -
FTO Biology and Obesity: Why Do a Billion of Us Weigh 3 kg More?
por: Cheung, Man-Ka Marcella, et al.
Publicado: (2011)